were used as predictors of caregivers' longitudinal functional limitation trajectories. Care transitions and total number of ADS days per week at baseline were considered as moderators of the associations between stress biomarkers and health over time. Results: The associations between functional limitation trajectories and daily total outputs of cortisol and sAA were modified by ADS use and care transitions. Among caregivers who experienced a transition, and who used less than average ADS days per week, lower daily cortisol total output and lower daily sAA total output were associated with increasing functional limitations. Caregivers who experienced a transition but used greater than average ADS days per week did not show such patterns of association. No significant effect was found for DHEA-s. Conclusion: The study contributes to an important but largely unanswered question regarding implications of stress biomarkers on functional health. Assessments of the association between stress biomarkers and health among family caregivers of persons with dementia need to consider changes in stressor exposures over time, such as care transitions and ADS use. 
thalamic-pituitary-adrenal (HPA) axis and sympathetic nervous system (SNS) have been found to be related to poor health outcomes [1] . For family caregivers of persons with dementia, high levels of chronic stress are associated with psychological as well as health changes [3] . Biological markers of the stress response may be the underlying mechanism between chronic stressor exposure and health decline.
Stress Reactivity as a Multidimensional Construct
The major part of the neuroendocrine systems that is closely associated with stress functioning is the HPA axis, which regulates many important bodily processes in response to stress such as metabolism and immune functions. Two of the primary hormones/mediators of the HPA axis are cortisol, and dehydroepiandrosterone (DHEA) and its sulfated form DHEA-s. Chronic stressors can disrupt cortisol output. Particularly, cortisol deficiency (hypocortisolism) has been related to disease pathogenesis such as posttraumatic stress disorder, rheumatoid arthritis, and chronic fatigue [4] . DHEA-s is co-released with cortisol in response to stressor exposure. However, DHEA-s is anabolic, while cortisol is a catabolic hormone [5] . Anabolic hormones such as DHEA-s (i.e., androgens) are important for stress and aging. At sufficient levels, anabolic hormones have restorative functions, whereas deficits in anabolic hormones may leave cortisol actions unopposed, and are associated with premature aging and increased risks of early mortality [5] . Studies have consistently reported the association between chronic stress and low levels of both DHEA-s and cortisol [6] .
Extensive research also suggests that stressors activate the SNS. One SNS marker, salivary alpha amylase (sAA), can serve as a sensitive, reliable, and noninvasive measure of experienced stress [7, 8] . As an enzyme, sAA is produced in the oral cavity by major salivary glands. Its release is elicited by the SNS activation, which controls the salivary glands. Levels of sAA parallel the response of norepinephrine to stressors. As with the HPA markers, sAA is often low in chronic stress situations [9] .
Biomarkers as Indicators of Pre-Disease Pathways
The concept of pre-disease pathways describes the biological influences that occur prior to the onset of diseases, functional decline, and mortality [10] . An important tenet of research on health is to evaluate these precursors to morbidity onset at distant time points, and to employ multiple indicators simultaneously, rather than focusing on a single biological marker [11] . Furthermore, multiple observations of a given biomarker over time can be a more informative and reliable measurement of biological responses to stressors [12] . Linking daily biomarkers to long-term measures of health allows for examination of possible pre-disease pathways and helps quantify the implications of stressor exposures for health.
Cortisol, DHEA-s, and sAA may have distinct associations with health and stress. Dysregulated cortisol in reactivity to chronic stress has been related to diseases such as rheumatoid arthritis and asthma [4] . Greater sAA stress reactivity was observed in children who had more parent-reported health problems and illnesses [13] . Further, lower DHEA-s levels were shown to be associated with increasing functional limitation, poorer subjective health, and increasing depressive symptoms [14] . HPA and SNS reactivity in response to chronic stress of caregiving, although rarely examined, may have similar health implications among family caregivers of persons with dementia. For example, hypocortisolism and lower sAA levels may be associated with poor functional health among these caregivers.
Health and Functional Limitations
Health is a multidimensional construct. One useful measure is functional limitations, which are a common outcome of multiple health conditions. Functional limitations are sensitive to the health effects of chronic stress, particularly for a sample in middle and late life, for whom stressors may exacerbate preexisting conditions as well as lead to incident illness [3, 15] . Furthermore, measures of functional limitations are less likely to be affected by the biases inherent in another widely used global measure, subjective health, where ratings often reflect comparisons with peers, rather than overall functioning [16] . Therefore, the objective measure of functional limitations is of particular salience in later life.
The Impact of Adult Day Services and Care Transitions on Stressor Exposures and Health
Family caregivers of persons with dementia experience on average high levels of daily stress during day and night, which can be associated with their compromised health and well-being [17] . Two factors that directly affect exposures to daily stressors are use of respite and transitions in the caregiving role, which in turn relate to caregiver health. Caregiving respite such as adult day services (ADS) programs provide a predictable amount of time away from the care receivers during the day. Research shows ADS can reduce daily exposure to care-related stressors by 40 percent and creating opportunities for caregivers to engage in self-care activities [17] . Regular ADS use has been found to be effective in lowering depressive symptoms and anger [18, 19] ; other studies have also found that caregivers report better self-efficacy in behavior management and enhanced general well-being as a result of ADS use [20] . Additionally, ADS use may be associated with better regulation of daily biomarkers. Caregivers showed improved cortisol awakening response (CAR) and daily total cortisol output among those with flattened CAR and low daily output on non-ADS days [21, 22] ; on days following ADS use, DHEA-s levels were also higher [23] . Research also shows that caregivers who received more days of respite were less likely to experience functional declines compared to caregivers using fewer days of adult day care [3] . Therefore, we expected ADS use would moderate the association between stress biomarkers and functional health.
Another factor affecting caregiving stress is care transitions. Although the transition itself is stressful in the short-run, it has the effect of decreasing exposures to care-related stressors and other caregiving responsibilities over time. One major transition across the course of caregiving is institutionalization or turning care over to another family member. Similar to but different from ADS use, which reduces care-related behavioral and emotional problems during daytime only, institutionalization can additionally reduce caregivers' exposure to care-related sleep disturbances at nighttime. Research shows nocturnal disturbances and disruptions in sleep routines present a significant source of objective stressor among family caregivers of persons with dementia, which closely relates to higher subjective burden, more depressive symptoms, and impairment in daytime function [24, 25] . Similar to daytime ADS use, institutionalization and modifications of care-related stressor exposures may arguably relate to better regulations of stress biomarkers. Therefore, compared with ADS use alone, institutionalization and getting further relief from the demands of around-the-clock care may have an ameliorating effect on caregiver health and functioning over time [26] .
Studies have found that institutionalization is associated with declining health of the caregiver [3] . More precisely, declining health may be a precipitant for caregivers' decision to place their relatives in a nursing home [26] . Buhr et al. [27] studied the reasons for nursing home placement based on a 3-year longitudinal study. Among caregivers who institutionalized their relatives, nearly half of them indicated their own health problems as the primary reason. Thus, it is important to consider effects of institutionalization when studying the possible associations between biomarkers at baseline and long-term health. Additionally, although admission into a nursing home or similar institutional setting is the most common type of placement, caregivers may turn care over to another family member. As with institutionalization, this transition may have positive benefits for caregivers by lowering daily care-related stressor exposures, but may also reflect a downward trajectory in caregivers' health. Thus, it should also be considered when evaluating longterm health outcomes. Therefore, the current study defines care transitions as institutionalization or turning care over to another family member, so that caregivers were no longer providing active care to their relatives at 6 or 12 months when the relative still needed the care.
The Current Study
The current study builds on prior research [3] and evaluates the extent of association between stress biomarkers and changes in functional health over a 1-year period among family caregivers of persons with dementia. Caregivers who initially participated in a study of the effects of ADS use on 3 biomarkers, cortisol, DHEA-s, and sAA, were followed for a 1-year period to examine associations of biomarkers obtained at baseline with their subsequent functional health. This study is among the first that explore the health implications of stress biomarkers over time using multiple indicators of both the HPA and SNS systems. Two factors that might moderate the effects of biomarkers on functional health outcomes were taken into account ( Fig. 1 ) . First, although all caregivers in the study were initially using ADS services, they varied in how much respite they received, and thus how much reduction they experienced in stressor exposures [19] . Therefore, the amount of ADS use was considered for its effect on functional health changes over time. Second, as care transitions may be associated with functional health over time, whether caregivers placed their relative in a nursing home or turned care over to someone else was also considered as a covariate. The hypotheses for this study are outlined below.
Hypothesis 1
We expect that the 3 stress-related biomarkers, cortisol, DHEA-s, and sAA, will be associated with declines in functional health. Additionally, this relationship will be moderated by caregiver transitions. Specifically, functional health declines will be associated with lower daily total outputs of cortisol, DHEA-s, and sAA, but the associations between functional health and stress biomarkers will be most pronounced among caregivers who had a transition out of the role, compared to others who continued providing care.
Hypothesis 2
We expect that ADS use at baseline will further moderate the association between the 3 biomarkers and health. Specifically, among caregivers who had a transition, and who used fewer ADS days at baseline, lower daily total output of all biomarkers will be associated with declining health over time.
Methods

Participants and Procedures
Participants were 184 primary caregivers who were providing care to a relative with dementia at baseline. Caregivers participated in an 8-day diary study and provided 5 saliva samples each day as part of the Daily Stress and Health (DaSH) study [19] . Eligibility included that (a) the caregiver and his/her relative lived in the same household, (b) the relative had a physician's diagnosis of a type of dementia (e.g., Alzheimer disease), (c) the relative attended ADS programs at least 2 days a week, and (d) the relative was alive throughout the entire study period. Caregivers subsequently completed follow-up telephone interviews at 6 months ( n = 182) and 12 months ( n = 174). One hundred and seventy-two caregivers participated in at least 2 data collections at baseline, and 6 and 12 months. The final working sample of caregivers ( N = 141) did not include those whose relatives were deceased at either 6 months or 12 months ( n = 31). There was a compelling reason for not combining bereaved caregivers with those who turned care over, because of differences in the implications of the transitions for health. Additionally, the number of bereaved caregivers was too small to examine them separately. Table 1 presents detailed transition types and the corresponding number of caregivers at specific follow-up time. Table 2 presents demographic characteristics of caregivers and their relatives.
Recruitment was conducted at ADS programs in Northern and Central New Jersey, the Philadelphia and Pittsburgh metropolitan areas, Northern Virginia, and Denver, CO. Caregivers from 57 programs contacted us over a 3-year period. Eligible caregivers completed an initial in-person interview. The interviewer obtained signed consent and sociodemographic information. The interviewer also trained participants in the use of a home saliva kit. The kit contained 40 color-coded Salivettes (Starsdet, Cary, NC, USA) and a home collection diary. For the next 8 days, participants collected saliva 5 times a day (i.e., before getting out of bed, 30-min after getting out of bed, before lunch, before dinner, and before bed). Saliva collection times were recorded on Salivettes and the home collection diary. Participants kept Salivettes in the refrigerator until the shipment to the lab at the end of daily sampling period. Daily telephone interviews were conducted in the evenings of the 8 days by interviewers from the Penn State Survey Research Center. In the interviews, participants reported daily stressors and affect, confirmed times of the saliva samples, and reported use of ADS services. On the last day they received Salivette shipping instructions. Participants were paid USD 150 for completing the entire study protocol. a Care transition was dummy coded, which represented the removal of caregiving happened at either 6 months or 12 months (= 1, otherwise = 0) when the relative was still living and needed active care.
b 172 family caregivers participated in at least two waves of data collection at baseline and 6 and 12 months. Two caregivers missed the 6-month interview; 3 caregivers missed the 12-month interview; 167 caregivers participated in all 3 waves. The analysis did not include bereaved caregivers whose relatives passed away at either 6 or 12 months (n = 31). The working sample of caregivers was N = 141.
c Total number of bereaved caregivers at either 6 or 12 months. d One caregiver who institutionalized the relative at 6 months missed the 12-month interview.
Once received at the Penn State Biomarker Core Lab, saliva samples were weighed, racked, and stored at -80° C. Salivary cortisol, DHEA-s, and sAA were determined using commercially available enzyme immunoassay kits (DiaMetra, Italy). At the time of assay, samples were brought to room temperature and centrifuged to separate mucin from clear saliva. Samples from each participant were tested in duplicate in a single assay batch. Duplicate test values that varied by more than 5% for cortisol and sAA, and 10% for DHEA-s were subject to repeat testing. Values used in data analyses are the averages of duplicate tests. A saliva sample was invalid [21, 28] if: (1) the caregiver was awake for less than 12 h or greater than 20 h ( n = 14), or (2) the caregiver woke up after 12 p.m. ( n = 0), or (3) for cortisol assay specifically, there was a greater than 10 nmol/L rise between the second (30 min after getting out of bed) and third samples (before lunch) ( n = 11), or (4) the recorded collection time between the first (upon wakeup) and second samples (30 min after getting out of bed) is either <15 min or >60 min ( n = 99).
Measures
Functional Health Limitation Functional health limitation was measured with a 9-item scale (α = 0.82) from the Medical Outcomes Studies (MOS) 36-item short form health survey (SF-36) [29] . It assessed degrees of limitation in physical activities: moderate activities such as pushing a vacuum, moving a table; carrying groceries; climbing stairs; bending, kneeling or stooping; walking; bathing and dressing [30] . Caregivers were asked about how much physical limitation (3-point scale; coded 1 = not limited, 2 = limited a little, 3 = limited a lot) they had in carrying out these activities, and higher scores indicated greater functional limitations.
Daily Biomarkers
The sample test volume for salivary cortisol was 25 μL. The assay had a lower limit of sensitivity of 0.03 μg/dL, with an average inter-and intra-assay covariance of less than 7 and 4%, respectively. Cortisol measurement units were converted to nmol/L (μg/ dL ×27.6). The sample test volume for salivary DHEA-s was 50 μL. The assay had a lower limit of sensitivity of 0.05 ng/mL. DHEA-s data were converted to nmol/L (i.e., ng/mL ×2.71). The sample test volume for sAA was 10 μL. Measurement units were expressed in nmol/L (ng/mL ×2.71). Original values without transformations were used for the analysis.
We summarized daily scores for each of the biomarkers, salivary cortisol ( n = 6,173, 94.5% valid), DHEA-s ( n = 5,988, 94.5% valid) and sAA ( n = 6,121, 95.6% valid) based on valid saliva samples. We computed daily total output for each observation day based on the existing formula for area under the curve with respect to ground (AUCg) [31] . The average daily total output (AUCg) was then calculated across the 8 days of observation at baseline and was used as the predictor of caregivers' longitudinal health trajectories for all 3 biomarkers.
Care Transitions . Care transitions were determined during the 6-and 12-month follow-up interviews. Based on their responses, caregivers who had placed their relative in an institution or turned the care over to another family member were coded as having a care transition (= 1 or 0 = did not have a transition).
ADS Use. The total number of days that caregivers were having ADS per week at baseline was operationalized as the extent of respite intervention (mean = 3.89 days, SD = 1.15 days).
Covariates. Additional variables from the baseline interview that are often associated with caregiver health were considered as covariates: caregiver age, relationship type (1 = spouse and 0 = other kin relationship), depressive symptoms [32] (depression subscale from the Non-Specific Psychological Distress scale; 7 items on a 5-point scale ranging from 1 = none of the day to 5 = all day; coded so that higher scores indicated more depressive symptoms; α = 0.81), caregiving role overload (3 items on a 4-point scale ranging from 1 = none of the time to 4 = all of the time; coded so that higher scores indicated more subjective experiences of being worn out and overloaded; α = 0.63) [33] , and caregiving role captivity (3 items on a 4-point scale ranging from 1 = none of the time to 4 = all of the time; coded so that higher scores indicated that the caregiving role was unwanted; α = 0.83) [33, 34] .
Analysis Plan
The hypotheses were tested using 3 growth curve models for each of the 3 biomarkers with functional limitation over 12 months as the outcome. Hypothesis 1 on the associations between biomarkers and functional limitations in the context of care transitions was tested using a full model with main effects and interactions (Model 1). Specifically, Model 1 tested the main effect of care transitions and biomarkers on health change as well as the interactions between care transitions and stress biomarkers on health change. The level 1 equation in Models 1 and 2 was specified as:
where caregiver health was modeled as a function of the intercept, the linear time, and the within-person residual term. Level 2 equations modeled the effects of daily stress biomarkers, and care transitions on caregiver health trajectories, while controlling for care- 
where β s are population-level parameters; the person-specific intercept, π 0 i , from equation (1) is now modeled as functions of average daily total outputs of cortisol, DHEA-s, sAA at baseline, and care transitions, while controlling for other caregiving characteristics; the person-specific linear time slope, π 1 i , is also modeled as functions of average daily total outputs of cortisol, DHEA-s, sAA at baseline, care transitions, and the interactions between each of the daily total outputs of stress biomarkers and care transitions. υ 0 i is between-person differences in the intercept with a variance, σ 2 υ . Model 1 tested the associations between functional health and each one of the biomarkers respectively, one at a time (Models 1.1, 1.2, and 1.3).
Next, to test Hypothesis 2 on ADS use, total ADS days per week at baseline were added to the model as an additional predictor in equation (2) (Model 2), while keeping the same level 1 equation as (1) . Thus, the level 2 equations in Model 2 were specified as: 
where the person-specific linear time slope, π 1i , is now modeled as functions of total ADS days at baseline, daily stress biomarkers (i.e., average daily total outputs of cortisol, DHEA-s, and sAA at baseline), care transitions, and the interactions between these 3 terms. υ 0 i is between-person differences in the intercept with a variance, σ 2 υ . Model 2 also tested the associations between func- 544 tional health and each one of the biomarkers respectively, one at a time. All between-person covariates on demographics and caregiving characteristics were grand-mean centered. ( Table 3 , Model 1). Model 1 did not show any significant main effects. However, Model 1 showed that care transitions had significant interactions on the associations between functional limitation trajectory over 12 months and daily total outputs of all 3 biomarkers. Specifically, care transitions moderated the associations between functional trajectory and daily total output of cortisol (β = -0.007, p < 0.0001, Model 1.1), DHEA-s (β = 0.002, p = 0.02, Model 1.2), and sAA (β = -0.0001, p = 0.0002, Model 1.3), as indicated by 3 significant 3-way interactions in the models. Among caregivers who experienced a transition, lower cortisol daily total output ( Fig. 2 ) , greater DHEA-s daily total output ( Fig. 3 ) , and lower sAA daily total output ( Fig. 4 ) was associated with increasing functional limitations over time. Parameter estimates from Model 1 are presented in Table 3 .
Results
Hypothesis 1 was supported partially
Next, Model 2 was fit to test Hypothesis 2 on the moderating effect of ADS use at baseline. The model showed that the extent of ADS use further modified the associations between functional limitation trajectory and daily total outputs of cortisol and sAA in the context of care transitions. First, the significant 4-way interaction in Model 2.1 (β = 0.004, p = 0.013; Table 4 ) showed that care transitions had an effect on the association between cortisol daily total output and functional trajectory, which in turn was modified by total ADS days. Specifically, among caregivers who experienced a transition, and who used less than average ADS days per week at baseline, lower daily cortisol total output was associated with increasing functional limitations ( Fig. 5 upper panel) . Caregivers who experienced a transition but used greater than average ADS days per week did not show such patterns of association ( Fig. 5 up- Table 4 ) showed that care transitions had an effect on the association between sAA daily total output and functional trajectory, which in turn was modified by total ADS days. Specifically, among caregivers who experienced a transition, and who used less than average ADS days per week, lower daily sAA total output was associated with increasing functional limitations ( Fig. 5 , lower panel) . Caregivers who experienced a transition but used greater than average ADS days per week did not show such patterns of association ( Fig. 5 ,  lower panel) . No significant effect was found for DHEA-s. All significant findings from Model 2 are presented in Table 4 . All models controlled for the same sets of covariates.
Discussion
This study is among the first to explore associations between daily biomarkers and long-term health among family caregivers of persons with dementia, and the moderating effects of care transitions and ADS use on such associations. The biological stress framework [1] and the caregiving stress process model [33] guided the study. Some of its strengths included the longitudinal measures on functional health, use of multiple biomarkers measured across days such that within-person variance was minimized, and the considerations of an intervention effect in the context of care transitions. We took into consideration factors that affected care-related stressor expo- All between-person covariates were grand-mean centered. ADS, adult day services; AIC, Akaike information criterion; BIC, Bayesian information criterion. Total ADS days were measured at baseline as the total number of ADS days used per week. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001. 
Biomarkers and Health in the Context of Care Transitions
The findings showed that although each of the stress biomarkers did not have significant main effects on functional health, trajectories of functional limitations over time were associated with daily stress biomarkers of both HPA and SNS in the context of care transitions. Prior studies examining associations between biomarkers and health change have used a much larger sample size, an index score based on multiple biomarkers, and performance-based measures on physical health such as balance and gait [35] . Possible explanations for null findings on the main effects of stress biomarkers on functional health include a relatively small sample, one type of stress biomarker reflecting HPA or SNS activity as the primary predictor, and self-reported functional status. The findings on lower cortisol and sAA daily total outputs were consistent with previous studies on the allostatic load model of chronic stress and health problems [2] . Prolonged exposure to stress hormones such as cortisol can be detrimental, causing neuron loss in the brain and posing chronic health problems. Hypocortisolism and lower sympathetic activity may imply a potential physiological mechanism for increased susceptibility to functional declines [6, 9] . Caregivers' deteriorating health can make providing care to a relative with dementia very challenging, making premature care transitions a much more likely option when care receivers do not yet require care at such a level. The fact that the association between hypocortisolism, lower sAA levels, and increasing functional limitation was only pronounced among caregivers with transitions confirmed that physical health is an important resource for caregiving roles [27] .
The finding on associations between greater DHEA-s levels and increasing functional limitations among caregivers who had transitions is a bit puzzling. Chronically stressed populations such as family caregivers of persons with dementia typically have reduced DHEA-s levels than nonstressed controls [36] . As an antagonist to cortisol, existing research generally suggests that lower DHEA-s levels were associated with greater health risks such as cardiovascular disease and all-cause mortality [2, 37] . Cross-sectional studies based on between-person associations also reported low DHEA-s values among women with poor functioning in daily activities [38] . Prior studies also suggested gender could be a contextual factor [39] . The fact that our sample consisted primarily of women caregivers may have contributed to the contradictory findings. However, it is not yet clear how DHEA-s would be associated with within-person changes in any health indicators over time, or whether self-reported functional limitation is a sensitive indicator for DHEA-s levels. More longitudinal studies are necessary to explore further the associations between DHEA-s, chronic stress, and health. Specifically, future studies need to consider the best way to integrate multiple stress biomarkers as predictors of objective measures of functional health over a longer period.
ADS Use, Caregiver Health, and Care Transitions
The findings on ADS use extend the literature on its psychological and physical benefits for family caregivers of persons with dementia [3, 19] . There was an interesting finding on the effect of baseline ADS use on the biomarker-health association in the context of care transitions. Among caregivers who turned care over, the ones who had fewer ADS days per week at baseline seemed to show an association between low cortisol levels and increasing functional impairment over time. Such association was not pronounced among caregivers who had more ADS days and who also placed relatives. The same patterns also applied to daily sAA total output. The significant 4-way interaction between biomarkers, health change, total ADS days, and care transitions confirms prior findings on the health benefits of ADS use [3] . Similar to a medical drug, there appeared to be a dosage effect for ADS use. Specifically, more than average ADS days per week (average = 3.86 days) seemed to bring greater physical benefits and protection against functional impairment. This finding is consistent with the literature on health benefits of caregiving respite [17] . It is possible that higher levels of ADS use allow caregivers to spend more time on self-care in addition to reduced stressor exposure. Future research needs to examine caregivers' time use, self-care activities, and well-being while their relatives attend ADS to elucidate the exact mechanism of its health benefits.
Limitations
There are some limitations to the study. First, there were only 3 measurement occasions on functional limitations over 12 months. A longer time span and more health dimensions are better to track longitudinal health changes as consequence of daily stress biomarkers. Second, biomarkers in the study were limited to neuroendocrine measures of SNS and HPA axis. To evaluate comprehensively the pre-disease pathways, biomarkers from other bodily systems are needed. Third, the sample of family caregivers in the current study is select in that they chose to use ADS at varying amount of days, and participated in both daily and longitudinal parts of the study. The sample size was relatively small, and consisted of primarily women caregivers. Therefore, we should exercise caution when generalizing the current findings to other populations of caregivers, in spite of the interesting findings on biomarkers and health associations.
The findings have implications for ways to support informal caregivers through public policies. Family caregivers provide the predominant majority of care to persons with dementia as well as to persons with other types of disabilities. This voluntary care is an important contribution to the economy [40, 41] . The value of family caregiving, however, has been largely unrecognized in policy making about the costs of long-term services and supports. The chronic stress of witnessing a close family member decline is painful; providing care under the enormity of such chronic stress can be detrimental to caregiver's well-being. Empirical studies have shown that caregiving respite such as ADS use can provide a predictable amount of relief to caregivers by lowering primary and care-related stressor exposures. The benefits of community-based ADS programs to caregiver health and well-being are therefore more realistic than hypothesized. However, states vary in the amount they cover ADS under Medicaid, so insurance coverage and hence potential outof-pocket expenses may affect ADS use despite its apparent health benefits for caregivers. How these programs may become part of the standard policy on routine caregiver support will have important implications for caregiver well-being and the quality of the nation's long-term services and support system.
